BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24853194)

  • 1. Radiation therapy for chemotherapy-resistant recurrent epithelial ovarian cancer.
    Machida S; Takei Y; Yoshida C; Takahashi Y; Koyanagi T; Sato N; Taneichi A; Saga Y; Fujiwara H; Suzuki M
    Oncology; 2014; 86(4):232-8. PubMed ID: 24853194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involved-field radiation therapy for locoregionally recurrent ovarian cancer.
    Brown AP; Jhingran A; Klopp AH; Schmeler KM; Ramirez PT; Eifel PJ
    Gynecol Oncol; 2013 Aug; 130(2):300-5. PubMed ID: 23648467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial.
    Chang JS; Kim SW; Kim YJ; Kim JY; Park SY; Kim JH; Jang TK; Kim YB
    Gynecol Oncol; 2018 Oct; 151(1):39-45. PubMed ID: 30146110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes.
    Skaznik-Wikiel ME; Lesnock JL; McBee WC; Beriwal S; Zorn KK; Richard SD; Krivak TC; Edwards RP
    Int J Gynecol Cancer; 2012 Feb; 22(2):232-7. PubMed ID: 22080886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local radiation therapy for localized relapsed or refractory ovarian cancer patients with or without symptoms after chemotherapy.
    Fujiwara K; Suzuki S; Yoden E; Ishikawa H; Imajo Y; Kohno I
    Int J Gynecol Cancer; 2002; 12(3):250-6. PubMed ID: 12060445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial.
    Dinkic C; Eichbaum M; Schmidt M; Grischke EM; Gebauer G; Fricke HC; Lenz F; Wallwiener M; Marme F; Schneeweiss A; Sohn C; Rom J
    Gynecol Oncol; 2017 Aug; 146(2):279-284. PubMed ID: 28528917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of weekly topotecan in the treatment of heavily pretreated recurrent epithelial ovarian and primary peritoneal cancer: the Kaohsiung Chang Gung experience.
    Hu CF; Ou YC; Fu HC; Chang Chien CC; Tsai CC; Wu CH; Lin H
    Taiwan J Obstet Gynecol; 2015 Feb; 54(1):43-7. PubMed ID: 25675918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group.
    Kunos CA; Sill MW; Buekers TE; Walker JL; Schilder JM; Yamada SD; Waggoner SE; Mohiuddin M; Fracasso PM
    Gynecol Oncol; 2011 Feb; 120(2):224-8. PubMed ID: 21075438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer.
    Oza A; Kaye S; Van Tornout J; Sessa C; Gore M; Naumann RW; Hirte H; Colombo N; Chen J; Gorla S; Poondru S; Singh M; Steinberg J; Yuen G; Banerjee S
    Gynecol Oncol; 2018 May; 149(2):275-282. PubMed ID: 29454514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study.
    Gao Y; Liu Z; Chen X; Luo W; Zhang L; Wang J
    BMC Cancer; 2011 Oct; 11():439. PubMed ID: 21989202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of CA(125) in the prediction of optimal interval debulking surgery and its prognosis in patients with epithelial ovarian cancer].
    Mu T; Li XP; Wang JL; Wang SJ; Wang Y; Sun XL; Cui H; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):566-70. PubMed ID: 23141174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External beam radiation with 'curative intent' in advanced ovarian cancer: an uncommon but rational management approach based on the natural history of cancer in an individual patient.
    Markman M
    Oncology; 2014; 86(4):230-1. PubMed ID: 24852917
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience.
    Hou MM; Wang Z; Janku F; Piha-Paul S; Naing A; Hong D; Westin S; Coleman RL; Sood AK; Tsimberidou AM; Subbiah V; Wheler J; Zinner R; Lu K; Meric-Bernstam F; Fu S
    Oncotarget; 2016 Jun; 7(23):35132-43. PubMed ID: 27147567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of apatinib in patients with recurrent epithelial ovarian cancer.
    Miao M; Deng G; Luo S; Zhou J; Chen L; Yang J; He J; Li J; Yao J; Tan S; Tang J
    Gynecol Oncol; 2018 Feb; 148(2):286-290. PubMed ID: 29248198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of long-term survivors of recurrent epithelial ovarian cancer.
    Iwase H; Takada T; Iitsuka C; Nomura H; Abe A; Taniguchi T; Sakamoto K; Takizawa K; Takeshima N
    Int J Clin Oncol; 2015 Feb; 20(1):143-9. PubMed ID: 24664306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative Radiation Therapy for Recurrent Ovarian Cancer: Efficacy and Predictors of Clinical Response.
    Jiang G; Balboni T; Taylor A; Liu J; Lee LJ
    Int J Gynecol Cancer; 2018 Jan; 28(1):43-50. PubMed ID: 29040187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival.
    Mardas M; Stelmach-Mardas M; Madry R
    Support Care Cancer; 2017 Mar; 25(3):795-800. PubMed ID: 27771784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Re-evaluation of interval debulking surgery in advanced epithelial ovarian cancer].
    Ma Y; Li Y; Cui H; Liang XD; Tang ZJ; Li XP; Zhao Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):355-60. PubMed ID: 22883524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Adding Bevacizumab to Paclitaxel + Carboplatin for Platinum-Sensitive Recurrent Epithelial Ovarian Cancer: A Propensity Score Matching Analysis.
    Hirasawa T; Machida H; Iida T; Ikeda M; Shida M; Mikami M
    Tokai J Exp Clin Med; 2018 Sep; 43(3):85-89. PubMed ID: 30191541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in patients with recurrent or refractory epithelial ovarian cancer.
    Satthapong D; Tangjitgamol S; Manusirivithaya S; Pataradool K
    J Med Assoc Thai; 2007 Mar; 90(3):411-9. PubMed ID: 17427513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.